If excreted, there are no data regarding the effects of tamoxifen in breast milk on the breastfed infant or breastfed animals, Primobolan Depot (Methenolone). However, direct neonatal exposure of tamoxifen to mice and rats not via breast milk produced 1 reproductive tract lesions in female rodents similar to those seen in humans after intrauterine exposure to diethylstilbestrol and 2 functional defects of the reproductive tract in Primobolan pills rodents such as Primobolan Depot (Methenolone) atrophy and arrest of spermatogenesis. It is not known if Nolvadex is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from Nolvadex, women taking Nolvadex should not breast feed. The long-term effects of Nolvadex therapy for girls have not been established. A reduction in breast cancer incidence was seen among participants in each of the subsets: A total of 28 and 10 invasive breast cancers were seen among participants 65 and older in the placebo and Nolvadex groups, respectively. Across all other outcomes, the results in this subset reflect the results observed in the subset of women at least 50 years of age.